(Q47305063)

English

Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysis

scientific article published on 9 September 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22862879

Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysis (English)

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22862879

type 2 diabetes

0 references

0 references

1 reference

based on heuristic

inferred from title

0 references

author name string

W Rathmann

1

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22862879

K Kostev

2

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22862879

J B Gruenberger

3

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22862879

M Dworak

4

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22862879

G Bader

5

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22862879

G Giani

6

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22862879

publication date

9 September 2012

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22862879

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22862879

15

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22862879

1

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22862879

55-61

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22862879

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01674.X

21 January 2018

DPP-4 inhibitors: impact on glycemic control and cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01674.X

21 January 2018

Tolerability of dipeptidyl peptidase-4 inhibitors: a review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01674.X

21 January 2018

Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01674.X

21 January 2018

Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01674.X

21 January 2018

Impact of hypoglycemia associated with antihyperglycemic medications on vascular risks in veterans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01674.X

21 January 2018

The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01674.X

21 January 2018

Comparisons of persistence and durability among three oral antidiabetic therapies using electronic prescription-fill data: the impact of adherence requirements and stockpiling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01674.X

21 January 2018

Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01674.X

21 January 2018

The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01674.X

21 January 2018

Persistence patterns with oral antidiabetes drug treatment in newly treated patients--a population-based study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01674.X

21 January 2018

An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01674.X

21 January 2018

Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01674.X

21 January 2018

Hypoglycaemia: current management and controversies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01674.X

21 January 2018

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01674.X

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01674.X

21 January 2018

Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01674.X

21 January 2018

Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01674.X

21 January 2018

Identifiers

10.1111/J.1463-1326.2012.01674.X

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22862879

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/22862879

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47305063&oldid=2151380695"